Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

308 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of dual antiplatelet therapy duration on clinical outcome after coronary bifurcation stenting: results from the EuroBifurcation Club registry.
Cirillo P, DI Serafino L, Gamra H, Zimarino M, Barbato E, Briguori C, Amat-Santos IJ, Chieffo A, Erglis A, Gil RJ, Kedev SA, Petrov I, Radico F, Niglio T, Nakamura S, Costa RA, Kanic V, Perfetti M, Pellicano M, Maric K, Tesorio T, Vukcevic V, Esposito G, Stankovic G; EuroBifurcation Club. Cirillo P, et al. Among authors: erglis a. Panminerva Med. 2023 Mar;65(1):1-12. doi: 10.23736/S0031-0808.22.04604-3. Epub 2022 May 13. Panminerva Med. 2023. PMID: 35546730
A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: the AVIO trial.
Chieffo A, Latib A, Caussin C, Presbitero P, Galli S, Menozzi A, Varbella F, Mauri F, Valgimigli M, Arampatzis C, Sabate M, Erglis A, Reimers B, Airoldi F, Laine M, Palop RL, Mikhail G, Maccarthy P, Romeo F, Colombo A. Chieffo A, et al. Among authors: erglis a. Am Heart J. 2013 Jan;165(1):65-72. doi: 10.1016/j.ahj.2012.09.017. Epub 2012 Nov 20. Am Heart J. 2013. PMID: 23237135 Clinical Trial.
Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T, Chieffo A, Meliga E, Capodanno D, Park SJ, Onuma Y, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Costopoulos C, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capranzano P, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A. Naganuma T, et al. Among authors: erglis a. JACC Cardiovasc Interv. 2013 Dec;6(12):1242-9. doi: 10.1016/j.jcin.2013.08.005. JACC Cardiovasc Interv. 2013. PMID: 24355114 Free article.
The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease.
Chieffo A, Tanaka A, Giustino G, Briede I, Sawaya FJ, Daemen J, Kawamoto H, Meliga E, D'Ascenzo F, Cerrato E, Stefanini GG, Capodanno D, Mangiameli A, Templin C, Erglis A, Morice MC, Mehran R, Van Mieghem NM, Nakamura S, De Benedictis M, Pavani M, Varbella F, Pisaniello M, Sharma SK, Tamburino C, Tchetche D, Colombo A; DELTA 2 Investigators. Chieffo A, et al. Among authors: erglis a. JACC Cardiovasc Interv. 2017 Dec 11;10(23):2401-2410. doi: 10.1016/j.jcin.2017.08.050. JACC Cardiovasc Interv. 2017. PMID: 29217002 Free article.
Randomised comparison of a biodegradable polymer ultra-thin sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients with de novo native coronary artery lesions: the meriT-V trial.
Abizaid A, Kedev S, Kedhi E, Talwar S, Erglis A, Hlinomaz O, Masotti M, Fath-Ordoubadi F, Lemos PA, Milewski K, Botelho R, Costa R, Bangalore S. Abizaid A, et al. Among authors: erglis a. EuroIntervention. 2018 Dec 7;14(11):e1207-e1214. doi: 10.4244/EIJ-D-18-00762. EuroIntervention. 2018. PMID: 30222120 Free article. Clinical Trial.
Mid-term outcomes after percutaneous interventions in coronary bifurcations.
Zimarino M, Briguori C, Amat-Santos IJ, Radico F, Barbato E, Chieffo A, Cirillo P, Costa RA, Erglis A, Gamra H, Gil RJ, Kanic V, Kedev SA, Maddestra N, Nakamura S, Pellicano M, Petrov I, Strozzi M, Tesorio T, Vukcevic V, De Caterina R, Stankovic G; EuroBifurcation Club. Zimarino M, et al. Among authors: erglis a. Int J Cardiol. 2019 May 15;283:78-83. doi: 10.1016/j.ijcard.2018.11.139. Epub 2018 Dec 2. Int J Cardiol. 2019. PMID: 30528620
New-generation drug-eluting stents for left main coronary artery disease according to the EXCEL trial enrollment criteria: Insights from the all-comers, international, multicenter DELTA-2 registry.
Tanaka A, Giustino G, Briede I, Sawaya FJ, Daemen J, Kawamoto H, Meliga E, D'Ascenzo F, Cerrato E, Stefanini GG, Capodanno D, Mangiameli A, Templin C, Erglis A, Morice MC, Mehran R, Van Mieghem NM, Nakamura S, De Benedictis M, Pavani M, Varbella F, Pisaniello M, Sharma SK, Tamburino C, Tchetche D, Colombo A, Chieffo A; DELTA 2 Investigators. Tanaka A, et al. Among authors: erglis a. Int J Cardiol. 2019 Apr 1;280:30-37. doi: 10.1016/j.ijcard.2018.12.003. Epub 2018 Dec 15. Int J Cardiol. 2019. PMID: 30595357 Clinical Trial.
A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction: the COOL AMI EU Pivotal Trial.
Noc M, Laanmets P, Neskovic AN, Petrović M, Stanetic B, Aradi D, Kiss RG, Ungi I, Merkely B, Hudec M, Blasko P, Horvath I, Davies JR, Vukcevic V, Holzer M, Metzler B, Witkowski A, Erglis A, Fister M, Nagy G, Bulum J, Édes I, Peruga JZ, Średniawa B, Erlinge D, Keeble TR. Noc M, et al. Among authors: erglis a. EuroIntervention. 2021 Aug 27;17(6):466-473. doi: 10.4244/EIJ-D-21-00348. EuroIntervention. 2021. PMID: 34031023 Free PMC article. Clinical Trial.
The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trial.
Böhm F, Mogensen B, Östlund O, Engstrøm T, Fossum E, Stankovic G, Angerås O, Ērglis A, Menon M, Schultz C, Berry C, Liebetrau C, Laine M, Held C, Rück A, James SK. Böhm F, et al. Among authors: erglis a. Am Heart J. 2021 Nov;241:92-100. doi: 10.1016/j.ahj.2021.07.007. Epub 2021 Jul 24. Am Heart J. 2021. PMID: 34310907 Free article. Clinical Trial.
Sex Differences in Outcomes After Percutaneous Coronary Intervention or Coronary Artery Bypass Graft for Left Main Disease: From the DELTA Registries.
Moroni F, Beneduce A, Giustino G, Briede I, Park SJ, Daemen J, Claude Morice M, Nakamura S, Meliga E, Cerrato E, Makkar RR, D'Ascenzo F, Lucarelli C, Capranzano P, Tchetche D, Templin C, Kirtane A, Buzman P, Alfieri O, Valgimigli M, Mehran R, Colombo A, Montorfano M, Chieffo A; DELTA, DELTA 2 Investigators* *. Moroni F, et al. J Am Heart Assoc. 2022 Mar;11(5):e022320. doi: 10.1161/JAHA.121.022320. Epub 2022 Feb 22. J Am Heart Assoc. 2022. PMID: 35189691 Free PMC article.
308 results